Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Afr…
$9.14-0.11%
报价 2026-11-06
市值
$40.19B
EV
–
PE (TTM)
21.8x
预期 PE
–
52 周区间距高点 -18.9%
$8.57$11.27
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Drug Manufacturers - Specialty & Generic| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| HLNHaleon plc | $40.19B | -0.1% | – | 61.8% | 21.8x | 14.3x | – | |
| TAKTakeda Pharmaceutical Company Limited | $66.35B | -0.8% | – | 59.5% | 79.2x | 9.8x | – | |
| TEVATeva Pharmaceutical Industries Limited | $49.65B | +2.0% | -0.7% | 55.5% | 93.0x | 30.3x | 39.5x | |
| ZTSZoetis Inc. | $32.81B | -3.3% | +3.8% | 70.5% | 18.9x | 14.2x | 14.3x | |
| VTRSViatris Inc. | $22.87B | +5.0% | +4.6% | 38.8% | – | 12.4x | 11.2x | |
| NBIXNeurocrine Biosciences, Inc. | $16.66B | +3.0% | +39.8% | 97.6% | 23.6x | 17.3x | 16.0x | 高增长 |
| ELANElanco Animal Health Incorporated | $12.86B | +8.7% | +10.1% | 56.9% | – | 23.7x | 31.5x | GARP |
| RDYDr. Reddy's Laboratories Limited | $12.42B | +2.6% | – | 55.2% | 18.5x | 12.5x | – | |
| AMRXAmneal Pharmaceuticals, Inc. | $7.01B | +3.5% | +6.2% | 42% | 41.2x | 14.1x | 78.8x | |
| 同行中位数 | – | – | +5.4% | 56.2% | 32.4x | 14.2x | 23.8x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
报告货币 GBP（非美元）暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。